Delivery Order SPE2DB22D2206-SPE2DB25FJP68
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $13,920.92 by the Defense Logistics Agency for ORSERDU 345 mg tablets (30-count package). The contract is a firm fixed-price delivery order with no set-aside designation, issued competitively on October 28, 2025, and scheduled for completion by November 19, 2025. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,954.56 for ORSERDU 345 mg tablets (30-count) on October 20, 2025, with completion scheduled for November 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded, non-set-aside contract. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,315.38 by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025. This firm fixed-price contract, which is a child order under a larger indefinite delivery vehicle, represents a non-competitive award with an ultimate completion date of August 28, 2025. The contract will be performed at the company's corporate office location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $125,467.20 by the Defense Logistics Agency's Medical Supply Chain on October 22, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of October 23, 2025, and involves no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,854.60 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for ultimate completion by September 5, 2025. The contract represents a continuation of AmerisourceBergen's substantial role as a critical federal medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,051.52 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for ultimate completion on July 15,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,733.26 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,100.30 by the Defense Logistics Agency's Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award demonstrates the company's ongoing role as a critical pharmaceutical and medical supply vendor to the federal government,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJP68Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 22, 2025, for Orserdu 345 mg tablets (30-count supply) with a ceiling value of $13,920.91. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award. The contract is performed at the vendor's Corporate Office location in Conshohocken, PA and supports the Defense Logistics Agency's medical supply chain operations. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. As the prime pharmaceutical vendor under this comprehensive global contract vehicle, AmerisourceBergen Drug Corp supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems worldwide. The award demonstrates the vendor's continued role as a critical supplier within the Defense Health Agency and broader federal medical procurement ecosystem through competitively-awarded, firm fixed-price delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 8/22/25 |